Techprecision (NASDAQ:TPCS), Inc. (NASDAQ:TPCS) specializes in the design, engineering and manufacture of high-precision automated machinery and turnkey production solutions. The company’s core offerings include assembly, test and inspection equipment, servo-electric press systems and custom packaging machines tailored for industries with stringent quality and regulatory requirements. TechPrecision’s products support medical device, pharmaceutical, consumer goods and industrial applications, delivering end-to-end services from concept development and prototyping to full-scale production and after-market support.
Founded in 1987 and headquartered in Fredericksburg, Virginia, TechPrecision operates two primary manufacturing facilities: its U.S. headquarters and an engineering and assembly plant in Zhuhai, China. This dual-site model allows the company to serve customers across North America, Europe and Asia, providing local engineering support alongside global supply chain capabilities. TechPrecision’s solutions are designed to meet international standards, including ISO certifications and U.S. Food and Drug Administration (FDA) requirements, ensuring reliable performance and regulatory compliance.
Under the leadership of President and Chief Executive Officer William Savastano, TechPrecision emphasizes innovation, quality control and close collaboration with customers throughout the project lifecycle. The management team leverages expertise in robotics, precision machining and automation software to optimize production efficiency, accelerate time-to-market and control costs. By partnering with original equipment manufacturers and contract producers, TechPrecision delivers tailored automation systems that enhance throughput, accuracy and product consistency in critical manufacturing environments.
